Moreover, experimental studies indicate that the MEOX2 and GLI-1 transcription factors can influence the genetic expression of EGFR, a key driver gene of non-small cell lung carcinomas (NSCLC), by modulating specific histone marks on its enhancer and promoter sequences. This evidence concerns the gene GLI1 and non-small cell lung carcinoma.